[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337440-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337440-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","comprehensive-analysis-of-psme3-from-pan-cancer-analysis-to-experimental-validation","Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation","","PSME3 is implicated in tumor progression, yet its prognostic significance across pan-cancer contexts and its role in tumor immunity remain insufficiently defined. This study integrates extensive RNA-sequencing resources from TCGA and GTEx, identifying abnormal PSME3 expression patterns and linking high PSME3 levels to worse clinical outcomes, especially in LIHC and LUAD. Functional enrichment suggests involvement in protein degradation, immune regulation, and stem cell control, supported by immune infiltration and checkpoint associations, with experimental validation showing positive CD276 regulation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comprehensive-analysis-of-psme3-from-pan-cancer-analysis-to-experimental-validation/337440/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comprehensive-analysis-of-psme3-from-pan-cancer-analysis-to-experimental-validation/337440.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does this study investigate about PSME3?","Question",{"text":63,"@type":64},"It evaluates PSME3’s prognostic value across pan-cancer types and its involvement in tumor immunity, which were previously unclear.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which datasets support the pan-cancer analysis in the study?",{"text":68,"@type":64},"The study uses extensive RNA-sequencing data from TCGA and GTEx databases.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental finding links PSME3 to tumor immunotherapy mechanisms?",{"text":72,"@type":64},"Experimental validation indicates that PSME3 positively regulates CD276, suggesting a therapeutic role in immunotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337440,1790141475,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","TYPE Original Research PUBLISHED 19 January 2024  \nDOI 10.3389/fimmu.2024.1295693  \nOPEN ACCESS  \nEDITED BY  \nTakaji Matsutani, Maruho, Japan  \nREVIEWED BY Peng Huang,  \nNanjing Medical University, China Alok Kumar,  \nKyoto University, Japan  \n*CORRESPONDENCE Yadong Guo  \n [1731191@tongji.edu.cn](1731191@tongji.edu.cn)[ ](1731191@tongji.edu.cn)Xin Ge  \n [xin.ge@tongji.edu.cn](xin.ge@tongji.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 17 September 2023  \nACCEPTED 03 January 2024  \nPUBLISHED 19 January 2024  \nCITATION  \nDong C, Guo Y, Yang Y and Ge X (2024) Comprehensive analysis of PSME3: from pancancer analysis to experimental validation. Front. Immunol. 15:1295693 .  \ndoi: 10.3389/fimmu.2024.1295693  \nCOPYRIGHT  \n© 2024 Dong, Guo, Yang and Ge. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nComprehensive analysis of PSME3: from pan-cancer analysis to experimental validation  \nChengyuan Dong 1,2†, Yadong Guo 3*†, Yanrong Yang4† and Xin Ge 1*  \n1 Department of Clinical Medicine, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China, 2School of Medicine, Anhui University of Science and Technology, Huainan, China, 3 Department of Urology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China, 4Tongji University Cancer Center, School of Medicine, Tongji University, Shanghai, China  \nPSME3 plays a signiﬁcant role in tumor progression. However, the prognostic value of PSME3 in pan-cancer and its involvement in tumor immunity remain unclear . We conducted a comprehensive study utilizing extensive RNA sequencing data from the TCGA (The Cancer Genome Atlas) and GTEx (Genotype-Tissue Expression) databases. Our research revealed abnormal expression levels of PSME3 in various cancer types and unveiled a correlation between high PSME3 expression and adverse clinical outcomes, especially in cancers like liver cancer (LIHC) and lung adenocarcinoma (LUAD) . Functional enrichment analysis highlighted multiple biological functions of PSME3, including its involvement in protein degradation, immune responses, and stem cell regulation. Moreover, PSME3 showed associations with immune inﬁltration and immune cells in the tumor microenvironment, indicating its potential role in shaping the cancer immune landscape. The study also unveiled connections between PSME3 and immune checkpoint expression, with experimental validation demonstrating that PSME3 positively regulates CD276 . This suggests that PSME3 could be a potential therapeutic target in immunotherapy. Additionally, we predicted sensitive drugs targeting PSME3 . Finally, we conﬁrmed in both single-factor Cox and multiple-factor Cox regression analyses that PSME3 is an independent prognostic factor. We also conducted preliminary validations of the impact of PSME3 on cell proliferation and wound healing in liver cancer. In summary, our study reveals the multifaceted role of PSME3 in cancer biology, immune regulation, and clinical outcomes, providing crucial insights for personalized cancer treatment strategies and the development of immunotherapy.  \nKEYWORDS  \nimmunotherapy, PSME3, tumor markers, CD276, LIHC  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nCancer, a leading cause of mortality in the world, is a persistent public health issue (1, 2) . Immunotherapy has emerged as a promising approach for treating various cancer types, such as melanoma, lung cancer, and lymphoma (3–5) . However, not all patients respond equally to immunotherapy (6), and there is a need fo","cbCaicHKDAE8mSJG","https://ap.wps.com/l/cbCaicHKDAE8mSJG","pdf",9094328,16,"English","# 1 Introduction\n## Cancer and immunotherapy need for biomarkers\n## PSME3 biological functions\n## Tumor microenvironment and immune interactions","[{\"question\":\"What question does this study investigate about PSME3?\",\"answer\":\"It evaluates PSME3’s prognostic value across pan-cancer types and its involvement in tumor immunity, which were previously unclear.\"},{\"question\":\"Which datasets support the pan-cancer analysis in the study?\",\"answer\":\"The study uses extensive RNA-sequencing data from TCGA and GTEx databases.\"},{\"question\":\"What experimental finding links PSME3 to tumor immunotherapy mechanisms?\",\"answer\":\"Experimental validation indicates that PSME3 positively regulates CD276, suggesting a therapeutic role in immunotherapy.\"}]","Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation | PDF",1790019151,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47b8de52ee4f9e3902fa84749b7d6ddf.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc0149418466413264c3f940704837dc.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60977f47caf56eaa5acc19c2c6ead4de.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/daf295010104ae3b0b29456ad49cb75d.webp",980,1385]